novel pharmaceutical compositions that are particularly suitable for oral administration of superoxide dismutases and that have good bioavailability and therapeutic efficacy . these compositions are made up of a combination of a superoxide dismutase and at least one lipids or proteins . the lipids are exemplified by ceramides , and the proteins are exemplified by prolamines or polymer films based on such prolamines . a pharmaceutically acceptable vehicle can also be included in the composition .